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Background: We describe an outbreak of Bullous Impetigo (BI), caused by a (methicillin susceptible, fusidic acid
resistant) Staphylococcus aureus (SA) strain, spa-type t408, at the neonatal and gynaecology ward of the Jeroen
Bosch hospital in the Netherlands, from March-November 2011.
Methods: We performed an outbreak investigation with revision of the hygienic protocols, MSSA colonization
surveillance and environmental sampling for MSSA including detailed typing of SA isolates. Spa typing was
performed to discriminate between the SA isolates. In addition, Raman-typing was performed on all t408 isolates.
Results: Nineteen cases of BI were confirmed by SA positive cultures. A cluster of nine neonates and three health
care workers (HCW) with SA t408 was detected. These strains were MecA-, PVL-, Exfoliative Toxin (ET)A-, ETB+, ETAD-,
fusidic acid-resistant and methicillin susceptible. Eight out of nine neonates and two out of three HCW t408 strains
yielded a similar Raman type. Positive t408 HCW were treated and infection control procedures were reinforced.
These measures stopped the outbreak.
Conclusions: We conclude that treatment of patients and HCW carrying a predominant SA t408, and
re-implementing and emphasising hygienic measures were effective to control the outbreak of SA t408 among
neonates.
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Bullous Impetigo (BI) is a superficial bacterial skin infec-
tion caused by Staphylococcus aureus (SA), mainly
affecting infants and young children. Bullous impetigo,
like regular impetigo, is not a notifiable disease in the
Netherlands; therefore there are no data on incidence
rates. In the Netherlands, impetigo is the third most
common skin disorder in children presented to the gen-
eral practitioner [1]. In 1987, the incidence rate of impe-
tigo of children under 18 years reported by general
practitioners (GP’s) in the Netherlands was 16.5 per
1000 patients, and rose to 20.6 per 1000 patients in 2001
[2]. The blistering of the skin in BI is caused by the* Correspondence: maike.koningstein@rivm.nl
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distribution, and reproduction in any mediumexfoliate exotoxins ET-A or ET-B [3]. Sometimes BI
evolves into the more serious staphylococcal scalded
skin syndrome (SSSS) [4-6]. The mortality rate of SSSS
in children is less than 5% [6].
An Epidemic European Fusidic Acid-resistant Impe-
tigo Clone (EEFIC) has been described in the United
Kingdom, Ireland, France and in Scandinavian countries
[7-10]. This clonal SA strain is characterized as spa type
171, or single locus variants t408, t659, t874, and t875.
The presence of exfoliative toxin A (ET-A) and often
ET-B, and low level fusidic acid resistance due to the
presence of chromosomal fusB are strongly associated
with impetigo [8,9].
Starting in March 2011, neonates presented with a
blistering skin disease at the hospital. In May, the hos-
pital infection prevention ward was notified by a resident
in paediatrics.ntral Ltd. This is an Open Access article distributed under the terms of the
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infection prevention ward.
The goals of this study were to investigate possible
routes of transmission through observational studies and
typing of MSSA, and to establish adequate infection
control to stop the spread of MSSA t408 in the hospital.
Materials and methods
The hospital
The Jeroen Bosch Hospital is a tertiary teaching hospital
with a coverage area of 350,000 of the Dutch population.
The number of clinical bed-days in 2010 was 195,269.
On average, patients of the gynaecology and obstetrics
departments stayed for 2.8 days. In 2010, a total of 2500
in-house deliveries were performed, of which approxi-
mately 20% were caesarean sections. The hospital has 45
nursery beds and 4.2 full-time equivalent infection pre-
vention staff. In the end of April 2011 (during the out-
break) the hospital changed location to a newly build
hospital in the same city.
Case definition
Cases were defined as neonates presenting in the hos-
pital with a blistering skin infection (impetigo) with a
culture proven SA, starting from 15 March 2011, and
notified to the infection control department. A probable
case was defined as a neonate with a blistering skin dis-
ease, seen by one of the doctors at the Jeroen Bosch
Hospital, in the same period of time as a case, but with-
out any laboratory confirmation.
Cases
In March 2011, a first and second probable case pre-
sented at the hospital: both neonates presented with a
blistering skin disease. In April, two more probable cases
presented with the same blistering symptoms. The first
three cases were not hospitalised at the same time. In
May, nine more cases presented with IB. These cases
had an overlapping hospital stay and were considered a
cluster. By this time, the hospital infection prevention
department was notified by a resident in paediatrics.
The microbiology and hospital infection prevention
department was notified and an investigation was started.
Since the beginning of May, all S. aureus samples col-
lected from neonates were kept for elaborate typing. In
the next three months, another 15 neonates were identi-
fied, and after a stretch of two months in which no new
cases presented, we found one last case in November. The
nursery is a closed unit for in-house births. Infection con-
trol nurses performed audits and interviews on adherence
to the hygienic and cleaning protocols in the operating
room (3×), at the departments of neonatology (2×), and
obstetrics (7×). Breaches of Intensive Care practices are
corrected in collaboration with HCW from the unit.Laboratory methods
Spa typing
PCR amplification of the spa gene was done as described
before [11]. The size of the PCR products was deter-
mined on an Agilent 2100 Bioanalyzer (Agilent Tech-
nologies Netherlands BV, Amstelveen, The Netherlands)
with a sizing accuracy of 10% (http://medsci.udel.edu/
cores/bcl/bioanalyzer.html). For the neonatal isolates all
spa gene PCR products were sequenced. For the HCW
spa gene, PCR products within the 10% range of the size
of spa type t408 (415 bp), 415 ± 10% (374–457 bp), were
sequenced. For sequencing PCR products were purified
by means of USBW ExoSAP-ITW PCR Product Cleanup
(Affymetrix UK Ltd). Sequences were generated using
the BigDye terminator v1.1 Cycle Sequencing kit (Ap-
plied Biosystems/Life Technologies) according to manu-
facturer’s instructions with the above primers, and
analysed using Sequence Scanner software version 1.0
(Applied Biosystems/Life Technologies). The software
Ridom StaphType (http://www.spaserver.ridom.de/) was
used for spa sequence analysis.
Raman typing
Raman spectroscopy was performed according to the
manufacturer’s protocol (SpectracellRA bacterial strain
analyzer, River Diagnostics, Rotterdam, The Netherlands).
In short, SA strains were analysed after 20-hrs incubation
on Trypticase Soy Agar. The biomass was re-suspended in
5μl sterile milliQ and transferred onto the sample carrier.
The sample carrier was measured in the SpectracellRA at
785nm laser. The ‘Raman-shift’, indicated as the alter-
ation in wavelength of a laser due energy absorbance of
molecules within the bacteria, creates a unique spectrum
for each bacterial strain. These spectra of the strains were
compared. From the resulting 2-dimensional checker-
board plot clonal relationships were established using the
squared Pearson correlation coefficient (R2). Instrument
settings were set at sensitivity of 92.2%, based on a false
positive result of 1.0% and a false negative result of 3.0%
as defined by the manufacturer.
Screening health care workers
All HCW of the neonatal ward and all paediatricians
have been requested to participate in screening rounds
three times; in May, June and August. To maximize the
yield for each person a nose-swab from both the left and
right nostril were taken. A total of 564 samples were
taken form 226 HCW.
Outbreak investigation
To analyse whether the t408 strain had been circulating
in the hospital before we noticed, a trend analysis was
performed on data from January 2007 - September 2011,
Table 1 Overview patients and their spa- and Raman
types
Patient Month Spa-type Raman Symptoms
A May t408 Separate
type
yes
B May t408 Cluster yes
C May t408 Cluster yes
D June t408 Cluster yes
E June t279 - yes (after 11 days)
F June t408 Cluster unknown
G June t505 - yes
yes, and twin
brother
H July t408 Cluster of F
I July t408 Cluster yes
J July t091 - yes
K July t279 - yes
L August t026 - yes
M August t026 - yes
N August t9259 - yes
O August t408 Cluster yes
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after birth. We analysed the amount of FusR of S. aureus
(vitek, bioMérieux, Durham, USA) of previous years and
compared it to the number of FusR during the outbreak
period, using chi-square statistics of SAS 9.2 for
Windows (SAS Institute).
As part of a “search and destroy policy” contact
screening was performed for each case, meaning that
hospital staff, and other hospital patients that were in
contact with a case were screened for SA, which is
standard practice in case of an MRSA patient, even
though this outbreak was due to an MSSA. Only neo-
nates with symptoms were cultured, clinicians were
advised to culture neonates with symptoms. As a proxy
for a case one sister of a potential case was tested.
In addition to the staff-screening for SA, we also per-
formed environmental cultures using dry cotton swabs
from incubators, resuscitation tables, a resuscitation
case, trolleys, and various utensils in patient rooms and
the OR in May and June.
The communication department and the regional pub-
lic health department were involved in writing explana-
tory letters to parents of cases and probable cases.P November t408 Cluster yes
Staff
Q t408 Separate
family cluster
no
R t408 Cluster non
S t408 Cluster noResults
Cases
Following the case definition, a total of 19 cases were
found. In one case (D) a sister was found positive. An-
other ten probable cases with clinical impetigo bullosa,
but without laboratory confirmation (spa typing), were
identified, Figure 1. For 26 of the 29 cases and probable
cases swabs were obtained yielding SA positive cultures,
Figure 1. To discriminate among SA isolates, 16 cultures
were available for spa typing and yielded various spa
types with one cluster of 9 of spa type t408, Table 1. Spa0
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Figure 1 Number of total cases in the Impetigo Bullosa
outbreak, Jeroen Bosch Hospital, 's Hertogenbosch, The
Netherlands, March-November 2011.types of the other seven IB patients were t026 (L and M),
t279 (E and K), t505 (G), t091 (J) and t9259 (N).
Screening of health care workers
In three separate screening rounds a total of 564 samples
were taken from 226 HCW, in time-frames of May-June,
June-July, and August-October. These 226 HCW repre-
sent 96% of the total number of HCW present at the
departments during these three screening rounds. A total
of 131 SA positive cultures (23%) were found. Three iso-
lates (0.5%) were identified as SA spa type t408. The
HCW carrying t408 were a medical officer-paediatrician
(R, nasal carriage) and two nurses (Q and S, both with
nasal and throat carriage). One of the isolates (from Q)
contained both spa type t408 and t171, a single locus
variant of t408. Positive staff members were restricted
from the hospital for five days during the treatment
period and were treated with a combination of Bactroban
skin and nose ointment (for nose and perineum), Chloor
hexidine suction tablets, Hibi scrub shampoo, oral Tri-
methoprim bd 200 mg, and Rifampicine od 600 mg for
10 days. All HCW ceased to be carriers after treatment.
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isolates
All 12 identified SA t408 strains were fusidic acid resist-
ant (EUCAST criteria) with MIC values 3–8 mg/L, while
the non-t408 SA strains were fusidic acid sensitive. In
addition, the SA t408 strains were MecA-, PVL-, ETA-,
ETB+, and enterotoxin A-D negative.
Raman typing of the t408 strains (9 patients and 3
HCW) yielded one large Raman cluster with 8 cases (B-
D, F, H, I, O and P) and as well as 2 HCW (R and S).
Two other Raman types were found for the isolate of
HCW Q and the isolate of neonate A, Table 1.
Observation of infection control measures
Environmental swabs (n=73) taken from two resuscita-
tion tables as well as from all instruments used for re-
suscitation of neonates, were negative.
Environmental cultures (n=73) from swabs taken from
incubators, two resuscitation tables, a resuscitation case,
trolleys and various utensils in patient rooms, and the
OR in the months May and June were all negative. Ob-
servation and audits on adherence to infection control
practices yielded numerous targets for improvement
such as disposing of disposables, cleaning procedures,
storage, dress code and hand hygiene.
Discussion
Treatment of healthcare workers carrying SA t408, and
re-implementing and re-emphasising hygienic measures
were effective to control the outbreak of SA t408 among
neonates in the Jeroen Bosch Hospital. Rapid typing
tools are indispensable to support adequate infection
control measures. No new cases have been reported
since November 2011. However, increased awareness is
maintained in our setting to identify new cases. Further-
more, it is recommended that all fusidic acid resistant
strains isolated from neonates are typed and analysed for
possible clustering with other isolates in our hospital.
Routine surveillance of MSSA is not common practice
in The Netherlands, so the epidemiology of MSSA and
of specific methicillin susceptible isolates, such as t408,
is largely unknown. This MSSA type, t408, is possibly
linked to the EEFIC clone, which has caused outbreaks
at neonatal wards causing BI and SSSS in several Euro-
pean hospitals [8,10,12]. EEFIC is most commonly seen
as t171 but has also has been described as single locus
variants t408, t659, t874, and t875 [9]. All belong to
MLVA complex 123 [pers. comm., de Neeling].
All newly identified SA t408 strains were fusidic acid
resistant (EUCAST criteria) with MIC values 3–8 mg/L,
while the non-t408 SA strains were fusidic acid sensitive.
Considering the number of fusidin resistant (R) S aureus
isolated from 2007 until 2011 in neonates in our hospital
(total of 188 MSSA S aureus isolates on unique patientsof max. 31 days old), we noticed a significant increase
starting from the third quarter in 2010. In addition,
the here described SA t408 strains were MecA-, PVL-,
ETA-, ETB+, and ETAD-, like most other EEFIC strains
[7-10,13,14].
Recently, Rijnders et al. [15] studied this EEFIC clone
in the South of the Netherlands by examining skin and
soft tissue infections (SSTI) at GPs in 2007–2008. Of all
participating SSTI patients seen by GPs in the southern
part of the Netherlands, approximately 2.5% carried
t408. This finding leaves room to speculate whether the
cases described here were either related to a local out-
break, or a representative sample of the MSSA circulat-
ing in the community at the time. On the other hand,
re-implementing stricter hygienic protocols did have an
impact on the amount of new cases, suggesting a local
outbreak was controlled.
Moreover, no overlap in hospital stay between was
seen for some of the clustered cases. Patient P (Table 1)
was found in November of 2011, three months after the
last case of t408 was found. Patient A - the first case to
be spa typed - had an unrelated Raman-type compared
to the cases that were typed later.
Unfortunately, we have no data on frequencies of cir-
culating methicillin susceptible SA spa types in the area
of our hospital. This study shows spa type t408 in nine
out of sixteen neonatal cases, in contrast to surveillance
cultures among HCW which yielded only three t408
among 131 isolated MSSA. It is possible that t408 is the
predominant strain amongst neonates in our area.
Raman typing appears to be a convenient method for
epidemiological typing in an outbreak situation. It has
superior discriminative power compared to spa-typing,
which was not specific enough to distinguish between
patient A (Table 1) and the cluster that was found. Pa-
tient A was the first typed t408 patient and had an unre-
lated Raman type. Raman-typing is highly specific, is fast
(within an hour) with high throughput, and is an easy-
to-use method for outbreak situations [16]. In this study
both spa-typing and Raman typing were used. Ideally,
real time results identifying the incriminated strain
would be most desirable to adequately install infection
control measures. Spa-typing is more laborious than
Raman typing and has possibly less discriminative power
for this typical application (i.e. S. aureus t408). Raman
typing is an expensive technique and specific equipment
is needed. An important drawback of Raman typing is
that the output data are not easily comparable between
different databases since the output data can not be
translated into exact numbers (as in spa typing). There-
fore, Raman typing is not suitable for large scale out-
break settings or (inter)national surveillance.
From the observation at the operation theatre we con-
cluded that it was highly unlikely that a member of the
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there is no direct skin contact between the operating
team and the neonate. However possible sources of con-
tamination existed because the resuscitation table was
not properly cleaned, materials from previous caesareans
were still present at the table, and a cleaning protocol
for the resuscitation table did not exist.
Our advice was to devise a protocol for the cleaning of
the table, and to write a protocol for twin deliveries,
since this was missing.
During the observation of the neonatal ward we con-
cluded that the resuscitation table, emergency trolley,
and the incubators were not cleaned properly. Therefore
we took environmental swabs of these surfaces as well.
We also concluded that in the storage room no clear
division between sterile and non-sterile products was
maintained. We also noticed that a clear cleaning pro-
tocol was missing. These points were taken to the relevant
wards/nurses and the hygienic protocols were sharpened/
re-implemented.
Because most of our IB cases were caused by MSSA
strains other than t408, we are interested to do a follow-
up study where we will not only focus on bullous impe-
tigo, but also on other impetigo cases seen in child day-
care centres and GPs, to get a better understanding of
the epidemiology of virulent MSSA strains amongst
infants and older children.
Our outbreak peaked early summer in May, and lasted
from March until August, with one last case in
November. It seems unlikely that this outbreak can be
linked to the yearly increase in impetigo cases that is
seen in day-care centres and nurseries in late summer,
since our outbreak didn’t peak in late summer [1,2,17].Conclusions
In conclusion, we think this outbreak could have been
caused by failing infection control practices and short-
comings in infection control protocols. Another option
is that this outbreak is a reflection of bullous impetigo
found in the general population outside of the hospital;
the EEFIC cluster is regularly seen in European hospi-
tals. We consider Raman typing to be useful for use in
outbreak situations in small settings. Finally, we would
advocate gathering more surveillance data on circulating
methicillin susceptible SA strains.
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